Risk factors for sporadic Creutzfeldt-Jakob disease

Annals of Neurology

Volumn 63, Issue 3, 2008, Pages 347-354

  Ward, Hester J T ^a,c   Everington, Dawn ^a   Cousens, Simon N ^b   Smith Bathgate, Blaire ^a   Gillies, Michelle ^a   Murray, Katy ^a   Knight, Richard S G ^a   Smith, Peter G ^b   Will, Robert G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ABDOMINAL SURGERY; ADULT; APPENDECTOMY; ARTICLE; BREAST SURGERY; CARDIOVASCULAR SURGERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DENTAL SURGERY; DISEASE ASSOCIATION; EAR SURGERY; EYE SURGERY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; RISK FACTOR; SKIN SURGERY; SURGICAL TECHNIQUE; TONSILLECTOMY; VASECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CREUTZFELDT-JAKOB SYNDROME; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RISK FACTORS;

EID: 41849101689     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21294     Document Type: Article

References (37)

1. Nevin S, McMenemey WH, Behrman S, Jones DP. Subacute spongiform encephalopathy: a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain 1960;83:516-563.
2. Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery [letter]. Lancet 1977;1:478-479.
3. Gibbs CJ Jr, Asher DM, Kobrine A, et al. Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 1994;57:757-758.
4. Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982;45:235-238.
5. Duffy P, Wolf J, Collins G, et al. Possible person to person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-693.
6. Heckmann JG, Lang CJG, Petruch F, et al. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry 1997;63:388-390.
7. Brown P, Preece M, Brandel J-P, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-1081.
8. Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998;95:13363-13383.
9. Head MW, Ritchie D, Smith N, et al. Peripheral tissue involvement in sporadic, iatrogenic and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 2004;164:143-153.
10. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistance prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358:171-180.
11. Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001;358:208-209.
12. sc in the skeletal muscle of patients with variant, iatrogenic and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 2006;168:927-935.
13. Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003;349:1812-1820.
14. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathies: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-529.
15. Weissman C, Enari M, Klohn PC, et al. Transmission of prions. J Infect Dis 2002;186(suppl 2):S157-S165.
16. Ward HJT, Everington D, Croes EA, et al, for the European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Sporadic Creutzfeldt-Jakob disease and surgery - a case control study using community controls. Neurology 2002;59:543-548.
17. Collins S, Law MG, Fletcher A, et al. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:693-697.
18. Sanchez-Juan P, Ward HJT, De Silva R, et al. Ophthalmic surgery and Creutzfeldt-Jakob disease. Br J Ophthalmol 2004;88:446-449.
19. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000;47:575-582.
20. Department of Health. Monthly Creutzfeldt-Jakob disease figures. Available at: http://www.dh.gov.uk/en/Policyandguidance/ Healthandsocialcaretopics/CJD/DH_4120472. Accessed November 22, 2007.
21. National Centre for Social Research. Available at: http://www.natcen.ac. uk. Accessed November 22, 2007.
22. Ward HJT, Everington D, Cousens SN, et al. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006;59:111-120.
23. Schlesselman JL. Case control studies. New York: Oxford University Press, 1982.
24. Huber PJ. The behaviour of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics and Probability. Berkeley, CA, University of California Press, 1967:221-233.
25. Rogers WH. Regression standard errors in clustered samples. Stata Tech Bull 1993;13:19-23.
26. Heath CA, Barker RA, Esmonde TFG, et al. Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK. J Neurol Neurosurg Psychiatry 2006;77:880-882.
27. Bobowick AR, Brody JA, Matthews MR, et al. Creutzfeldt-Jakob disease: a case-control study. Am J Epidemiol 1973;98:381-394.
28. Kondo K, Kuroiwa Y. A case-control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982;11:377-381.
29. Davanipour Z, Alter M, Sobel E, et al. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985;35:1483-1486.
30. Harries-Jones R, Knight R, Will RG, et al. Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988;51:1113-1119.
31. Zerr I, Brandel J-P, Masullo C, et al. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 2000;53:747-754.
32. Wientjens DPWM, Davanipour Z, Hofman A, et al. Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology 1996;46:1287-1291.
33. De Pedro-Cuesta J, Bleda MJ, Rabano A, et al, EUROSURGYCJD Research Group. Classification of surgical procedures for epidemiological assessment of sporadic Creutzfeldt-Jakob disease transmission by surgery. Eur J Epidemiol 2006;21:595-604.
34. Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures. NHS National Institute for Health and Clinical Excellence. Interventional Procedure Guidance 196, November 2006. Available at: http://www.nice.org.uk/IPG196. Accessed November 22, 2007.
35. Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. Guidance from the Advisory Committee on Dangerous Pathogens and the Spongiform Encephalopathy Advisory Committee. Available at: http://www.advisorybodies.doh.gov.uk/acdp/tseguidance/Index.htm. Accessed November 22, 2007.
36. CJD Incidents Panel. Available at: http://www.hpa.org.uk/infections/ topics_az/cjd/incidents_panel.htm. Accessed November 22, 2007.
37. World Health Organization. WHO guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies. Available at: http://www.who.int/bloodproducts/tse/WHO%20TSE%20Guidelines%20FINAL- 22%20JuneupdatedNL.pdf. Accessed November 22, 2007.